Lidokain Aguettant (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. This prevents the rapid influx of sodium ions needed for depolarization, thereby inhibiting the initiation and conduction of nerve impulses and producing a reversible, localized anesthetic effect.

The appropriate dose of Lidokain Aguettant is determined by the prescribing clinician based on the procedure, patient weight, age, and overall health. Healthcare professionals calculate the total allowable dose to stay within safety limits and adjust the volume administered accordingly.

Safety data for lidocaine in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be prescribed by a qualified healthcare provider after careful assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for many short procedures. Compared with ester‑type agents such as procaine, lidocaine has a lower incidence of allergic reactions and a more predictable pharmacokinetic profile, though alternatives like bupivacaine may offer longer lasting anesthesia.

Store Lidokain Aguettant at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture, direct sunlight, and extreme temperatures. Do not freeze the solution, and ensure the container is sealed when not in use.

Lidokain Aguettant is supplied as a sterile solution for injection. It can be administered by infiltration into the target tissue, intradermally for superficial anesthesia, or intravenously for regional (Bier block) anesthesia. Administration is performed by qualified healthcare professionals following aseptic technique.

Serious risks include central nervous system toxicity (such as seizures), cardiovascular effects (including arrhythmias, hypotension, or cardiac arrest), severe allergic reactions (anaphylaxis), and methemoglobinemia. Prompt recognition and supportive management are essential if any of these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals taking interacting medications that could raise lidocaine levels (e.g., class I antiarrhythmics) should avoid its use unless a specialist determines that benefits outweigh risks.